META vs ZYME · P/E 29, rev $200.97B vs rev $76.3M
Meta Platforms Inc. (META) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Meta Platforms Inc. (META) is a internet content & information company listed on US. It is led by Mark Zuckerberg.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported META revenue for 2025-12-31 was $200.97B. Net income was $60.46B. Revenue was up 22.2% from 2024-12-31 to 2025-12-31. META currently screens at market cap $1.64T and trailing P/E 28.8.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
META currently screens at market cap $1.64T and trailing P/E 28.8. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the META and ZYME stock pages for the full models.
Not investment advice.